177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.

Bibliographic Details
Title: 177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.
Authors: Hernandez, Reinier, Grudzinski, Joseph J., Aluicio-Sarduy, Eduardo, Massey, Christopher F., Pinchuk, Anatoly N., Bitton, Ariana N., Patel, Ravi, Zhang, Ray, Kumar, Aakarsha V., Iyer, Gopal, Engle, Jonathan W., Weichert, Jamey P.
Source: Journal of Nuclear Medicine; Dec2019, Vol. 60 Issue 12, p1-25, 32p
Database: Complementary Index
More Details
ISSN:01615505
DOI:10.2967/jnumed.119.236265
Published in:Journal of Nuclear Medicine
Language:English